Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients:: Roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification

被引:49
|
作者
de Vries, R. [1 ]
Groen, A. K. [2 ]
Perton, F. G. [1 ]
Dallinga-Thie, G. M. [3 ]
van Wijland, M. J. A. [2 ]
Dikkeschei, L. D. [5 ]
Wolffenbuttel, B. H. R. [1 ]
van Tol, A. [1 ,4 ]
Dullaart, R. P. F. [1 ]
机构
[1] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, NL-9700 RB Groningen, Netherlands
[2] Acad Med Ctr, Dept Expt Hepatol, Groningen, Netherlands
[3] Erasmus Univ, Med Ctr, Lab Vasc Med, Rotterdam, Netherlands
[4] Erasmus Univ, Med Ctr, Dept Cell Biol & Genet, Rotterdam, Netherlands
[5] Isala Clin, Dept Clin Chem, Zwolle, Netherlands
关键词
ATP-binding cassette transporter type 1; cholesterol efflux; human fibroblasts; pre beta-HDL; reverse cholesterol transport; triglycerides; type 2 diabetes mellitus;
D O I
10.1016/j.atherosclerosis.2006.12.027
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We tested whether hypertriglyceridemia associated with type 2 diabetes mellitus is accompanied by alterations in pre beta-HDL, which are considered to be initial acceptors of cell-derived cholesterol, and by changes in the ability of plasma to promote cellular cholesterol efflux. In 28 hypertriglyceridemic and 56 normotriglyceridemic type 2 diabetic patients, and in 56 control subjects, we determined plasma lipids, HDL cholesterol and phospholipids, plasma pre beta-HDL and pre beta-HDL formation, phospholipid transfer protein (PLTP) activity, plasma cholesterol esterification (EST) and cholesteryl ester transfer (CET) and the ability of plasma to stimulate cholesterol efflux out of cultured human fibroblasts. HDL cholesterol and HDL phospholipids were lower, whereas plasma PLTP activity, EST and CET were higher in hypertriglyceridemic diabetic patients than in the other groups. Pre beta-HDL levels and pre beta-HDL formation were unaltered, although the relative amount of pre beta-HDL (expressed as % of total plasma apo A-I) was increased in hypertriglyeridemic diabetic patients. Cellular cholesterol efflux to plasma from hypertriglyceridemic diabetic patients was increased compared to efflux to normotriglyceridemic diabetic and control plasma, but efflux to normotriglyceridemic diabetic and control plasma did not differ. Multiple linear regression analysis demonstrated that cellular cholesterol efflux to plasma was positively and independently related to pre beta-HDL formation, PLTP activity and EST (multiple r=0.48), but not to the diabetic state. In conclusion, cholesterol efflux from fibroblasts to normotriglyceridemic diabetic plasma is unchanged. Efflux to hypertriglyceridemic diabetic plasma is enhanced, in association with increased plasma PLTP activity and cholesterol esterification. Unaltered pre beta-HDL formation in diabetic hypertriglyceridemia, despite low apo A-I, could contribute to maintenance of cholesterol efflux. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:733 / 741
页数:9
相关论文
共 50 条
  • [1] Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridaemic type 2 diabetic patients:: role of pre β-HDL and lipid transfer proteins
    Dullaart, R. P. F.
    de Vries, R.
    Groen, A. K.
    Dallinga-Thie, G.
    Perton, F.
    Wolffenbuttel, B. H. R.
    van Tol, A.
    [J]. DIABETOLOGIA, 2006, 49 : 744 - 745
  • [2] Avian phospholipid transfer protein causes HDL conversion without affecting cholesterol efflux from macrophages
    Saarela, Jani
    Metso, Jari
    Schneider, Wolfgang J.
    Jauhiainen, Matti
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (08): : 781 - 789
  • [3] ROLE OF THE PHOSPHOLIPID TRANSFER PROTEIN ACTIVITY IN THE IMPAIRMENT OF CELLULAR CHOLESTEROL EFFLUX IN TYPE 2 DIABETIC SUBJECTS
    Attia, N.
    Nakbi, A.
    Smaoui, M.
    Chaaba, R.
    Moulin, P.
    Hammami, S.
    Ben Hamda, K.
    Chanussot, F.
    Hammami, M.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 37 - 37
  • [4] Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease
    Attia, Nebil
    Nakbi, Amel
    Smaoui, Maha
    Chaaba, Raja
    Moulin, Philippe
    Hammami, Sonia
    Ben Hamda, Khaldoun
    Chanussot, Francoise
    Hammami, Mohamed
    [J]. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 213 (02): : 129 - 137
  • [5] Degradation of phospholipid transfer protein (PLTP) and PLTP-generated preβ-HDL by mast cell chymase impairs efflux of cholesterol from macrophages
    Lee, M
    Metso, J
    Jauhiainen, M
    Kovanen, P
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 69 - 69
  • [6] SEPARATION OF A PLASMA PHOSPHOLIPID TRANSFER PROTEIN FROM CHOLESTEROL ESTER PHOSPHOLIPID EXCHANGE PROTEIN
    TALL, AR
    ABREU, E
    SHUMAN, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (04) : 2174 - 2180
  • [7] Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients - Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase
    Tato, F
    Vega, GL
    Grundy, SM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) : 56 - 63
  • [8] EFFECT OF NONSPECIFIC PHOSPHOLIPID TRANSFER PROTEIN ON CHOLESTEROL ESTERIFICATION IN MICROSOMES FROM MORRIS HEPATOMAS
    VANHEUSDEN, GPH
    VANDERKRIFT, TP
    HOSTETLER, KY
    WIRTZ, KWA
    [J]. CANCER RESEARCH, 1983, 43 (09) : 4207 - 4210
  • [9] A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre β-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients
    De Vries, R
    Beusekamp, BJ
    Kerstens, MN
    Groen, AK
    Van Tol, A
    Dullaart, RPF
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2005, 65 (08): : 729 - 737
  • [10] HDL-MEDIATED EFFLUX OF INTRACELLULAR CHOLESTEROL IS IMPAIRED IN FIBROBLASTS FROM TANGIER DISEASE PATIENTS
    ROGLER, G
    TRUMBACH, B
    KLIMA, B
    LACKNER, KJ
    SCHMITZ, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (05) : 683 - 690